All News

2060 articles, sorted by publication time.

New Drugs and Clinical Research · us

Once-weekly antifungal seeks transplant prevention indication: rezafungin granted FDA priority review

The application for Rezzayo seeks to expand its use from treating infections to preventing fungal disease after allogeneic hematopoietic stem cell transplantation, with an FDA decision targeted for the first quarter of 2027. A Phase 3 trial supports the application, but approval of the new indication remains subject to a full benefit-risk review.

Biotechnology and Pharmaceuticals · eu

Microbiome Therapy Moves Toward Solid Tumor Trials: MaaT034 Receives Early Development Feedback from FDA

MaaT034 aims to improve responses to cancer immunotherapy through gut microbial functions. FDA feedback on its manufacturing and nonclinical development strategy provides clearer direction for preparations for human trials; however, the trial has not yet been authorized, and the proposed launch in late 2027 remains dependent on funding.

Medical Genetics · us

CD36 Variant Reveals Gap in Cardiomyopathy Genetic Testing: Estimated to Account for 9% of Disease Burden in People of African Ancestry

A study of more than 80,000 people suggests that a CD36 variant absent from routine testing may explain more of the overall cardiomyopathy burden in people of African ancestry than well-established cardiomyopathy genes. Cleveland Clinic plans to introduce clinical testing for the variant, but whether testing can improve care outcomes remains to be established.